call toll free 877-225-8384Mon - Fri 7 am - 9 pm Sat - Sun 8 am - 4 pm (CST)

Join the all-stars of
child & adolescent psychiatry

the world's most powerfully practical™ psychopharmacology course

Dear Colleague,

Great news - the entire Child Master Psychopharmacology Course is now available as a completely pharma-free Online Course. Now you can share in the down-in-the-trenches, no-nonsense prescribing guidance from the “All-Stars” of Child & Adolescent Psychiatry at your own pace. Plus, you earn up to 16.5 CME and 8 Self-Assessment credits by participating!

Online Course Materials

Detailed Lectures With Real-World Guidance:

Leading child and adolescent psychiatrists present detailed, real-world guidance and lead you through 16.5 intensive hours of high-yield lectures. The single-minded goal of The Master Psychopharmacology Course is to ensure your ability to implement what you learn. After all, it doesn’t matter what great things you hear and see if you don’t make use of them once you’re back in the office, sitting across your desk from a complex, treatment-resistant patient.

Earn Up to 8 Self-Assessment Credits:

To meet the ABPN's new requirements to sit for the MOC exam, we are providing up to 8 Self-Assessment Credits for participating. Regardless of whether you have an MOC exam coming up in 1 year or in 9 years, you need to start earning Self-Assessment credits now! We're including 8 Self-Assessment credits with this course to make it easy for you to keep up (or catch up!) with these new requirements.

Earn 16.5 Category 1 CME Hours:

These CME hours are included in your course tuition. Note that many employers, group practices and training programs will reimburse you for the costs of this Category 1 CME activity. So be sure to ask!

Get Online Access:

You receive flexible online access to the content. Every lecture is accessible as both streaming webinars on your computer and as video on your mobile device. Participants appreciate the chance to review the lectures to their heart’s content! We also ship you the thick course syllabus to aid your study and help you take notes.


Sign up today. You won't regret it!

Jack Krasuski MD

Jack Krasuski MD
Executive Director

-
Top

Course Agenda

1.75 Hours
Pharmacotherapy of Obsessive Compulsive Disorder in Children and Adolescents
  • The Science of Psychopharmacology of OCD in Children and Adolescents
  • Applying the Science to Caring for Youth with OCD
  • Case Presentations
Jefferson Prince, MD
2.25 Hours
Optimizing Pharmacotherapy: Building Better Brains in Depressed Children
  • Assessing Patient Constellations to Match Medications
  • Evidence-Based Augmentation Tactics
  • Psychopharmacology Plus: Enhancing Treatment Response
  • Case Presentations
Jeff Bostic, MD
1.5 Hours
Pharmacotherapy of Non-OCD Anxiety Disorders in Children and Adolescents
  • The Science of Psychopharmacology of OCD in Children and Adolescents
  • Applying the Science to Caring for Youth with OCD
  • Case Presentations
Jefferson Prince, MD
1.25 Hours
Partnering with Schools and Complex Families
  • Investing Schools as Partners in Treatment
  • Working with Difficult, Resistant, or Noncompliant Families
  • Improving Treatment Adherence
  • Case Presentations
Jeff Bostic, MD
2 Hours
Update on the Treatment of Substance Abuse in Adolescence
  • Clinical Management Considerations in the Care of Adolescents with Substance Use Disorders
  • Pharmacological Strategies Useful for the Management of Cravings and Urges in Adolescents With Cigarette Smoking and /or Substance Use Disorders
  • Pharmacological Treatment Strategies for Co-Occurring Psychiatric Disorders in Adolescents with Substance Use Disorders
  • Case Presentations
Timothy Wilens, MD
2 Hours
Update on Autism Spectrum Disorders
  • Advances in Neurobiology and Terminology
  • Advances in Psychopharmacology
  • Case Presentations
Steven Pliszka, MD
2.75 Hours
Doing Too Little or Going Too Far? The Art and Science of Complex Psychopharmacology
  • Doing Too Little or Going Too Far
  • Drug to Drug Interactions
  • What Science we have Regarding Psychopharmacology
  • Case Presentations
Steven Pliszka, MD
3 Hours
Update on Drug Treatment of Child and Adolescent ADHD
  • Overview of ADHD Treatment Options
  • Neurobiological Basis of Response
  • Current Issues and Hot Topics
  • Focus on Newly Approved Modalities and Approaches
  • Case Presentations
Steven Pliszka, MD
Top

Faculty


Jeff Q. Bostic, MD, EdD

Jeff Q. Bostic, MD, EdD

Titles/Affiliations/Positions:

  • Associate Clinical Professor, Harvard Medical School, Boston, MA
  • Director of School Psychiatry, Massachusetts General Hospital, Boston, MA
  • Medical Director, Massachusetts Child Psychiatry Access Project, Massachusetts General Hospital, Boston, MA

Education:

  • EdD, Texas Tech University, Lubbock, TX
  • MD, Texas Tech University, Lubbock, TX
  • Residency, Adult Psychiatry, Timberlawn Psychiatric Hospital, Dallas, TX
  • Fellowship, Child Psychiatry, Harvard Medical School, Boston, MA

Dr. Bostic has been involved in education for more than 30 years, providing psychiatric consultation to school districts throughout the Northeast. He has been an active participant in research on autism spectrum disorders, including the Studies to Advance Autism Research and Treatment Network funded by the National Institute of Mental Health. He has received several honors and awards for his work, including the "Sidney Berman Award" for contributions to school psychiatry.

Dr. Bostic has been a reviewer for several academic and professional journals and served on the editorial board as coeditor of Child and Adolescent Psychiatric Clinics of North America: Psychopharmacology and School Consultation.Dr. Bostic is also a member of several professional societies, including serving as the Chair of Continuing Medical Education for the American Academy of Child and Adolescent Psychiatry.

Steven Pliszka, MD

Steven Pliszka, MD

Titles/Affiliations/Positions:


  • Professor, The University of Texas Health Science Center at San Antonio, Department of Psychiatry, San Antonio, TX
  • Chief of the Division of Child & Adolescent Psychiatry, Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX

Education:

  • MD, University of Texas Health Science Center at San Antonio, San Antonio, TX
  • Residency in General Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX
  • Residency in Child and Adolescent Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX

Dr. Pliszka has been lecturing on the psychopharmacology of child and adolescent disorders for more than 15 years. His research has focused on attention-deficit/hyperactivity disorder (ADHD) and related disorders; he has been involved in clinical trials for most of the medications used to treat ADHD. Since 2008, he has directed Services Uniting Pediatrics and Psychiatry Outreaching to Texas (SUPPORT)- a state-funded initiative to integrate mental health services into pediatric primary care.

Dr. Pliszka is the author of Neuroscience for the Mental Health Clinician and Treating ADHD and Comorbid Disorders.He has also been very active in the American Academy of Child and Adolescent Psychiatry, authoring the academy's practice parameters for the diagnosis and treatment of ADHD.

Jefferson B. Prince, MD

Jefferson B. Prince, MD

Titles/Affiliations/Positions:


  • Instructor, Psychiatry, Harvard Medical School, Boston, MA
  • Director, Child and Adolescent Psychiatry, North Shore Medical Center, Salem, MA
  • Director, Pediatric Psychopharmacology and Outpatient Mental Health Clinics, North Shore Children's Hospital, Salem, MA

Education:


  • MD, Emory University School of Medicine, Atlanta, GA
  • Residency in Psychiatry and Acute Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA
  • Clinical Fellowship in Child Psychiatry, Massachusetts General Hospital & McLean Hospital, Harvard Medical School, Boston, MA

Dr. Prince is involved in research on the characterization and treatment of ADHD across the lifespan, as well as pediatric mood and anxiety substance disorders. Dr. Prince is interested in collaborations between pediatrics and psychiatry and serves as the Medical Director of the Massachusetts Child Psychiatry Access Project at North Shore Medical Center as well as a member of the Board of the Screening for Mental Health.

Dr. Prince is also the recipient of many awards and honors including the distinction of Laughlin Fellow for the American College of Psychiatrists. In 2005, Dr. Prince was selected as one of the "Best Doctors in America." He is the author or coauthor of more than 60 original articles, abstracts, and book chapters, and he has made more than 150 academic presentations nationally and internationally.

Timothy Wilens, MD

Timothy Wilens, MD

Titles/Affiliations/Positions:


  • Associate Professor, Psychiatry, Harvard Medical School, Boston, MA
  • Director of Center for Addiction Medicine, Massachusetts General Hospital, Boston, MA
  • Director of Adolescent Substance Abuse Services, Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA

Education:

  • MD, University of Michigan Medical School, Ann Arbor, MI
  • Residency in Child, Adolescent, Adult, and Addiction Psychiatry, Massachusetts General Hospital, Boston, MA

Dr. Wilens specializes in the diagnosis and pharmacological treatment of children and adults with ADHD, bipolar, substance abuse, and other psychopathological conditions. He cares for patients, supervises clinical trials, and consults on difficult cases-his expertise is sought both nationally and internationally.

Dr. Wilens has published more than 300 original articles, reviews, chapters, and editorials to his credit. He is a regular presenter at national and international meetings, and is sought as a speaker outside his academic responsibilities. He serves on the editorial boards of several journals and is a reviewer for many other journals. He is a distinguished fellow in the American Psychiatric Association, a fellow in the American Academy of Child and Adolescent Psychiatry, a member of the College of Problems on Drug Dependence and the World Psychiatric Association, and also serves on several committees within these organizations.

Dr. Wilens is also a consultant on substance abuse to both the National Football League and Major League Baseball, and is consistently named one of the "Best Doctors in America" for psychiatry.

Richard N. Rosenthal, MD

Richard N. Rosenthal, MD

Titles/Affiliations/Positions:


  • Professor of Clinical Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY
  • Chairman, Department of Psychiatry, St. Luke’s-Roosevelt Hospital Center, New York, NY
  • Senior Associate Dean, St. Luke’s Roosevelt Affiliation with Columbia University, New York, NY

Board Certifications:

  • Psychiatry
  • Addiction Psychiatry

Education:

  • MD, State University of New York, Downstate Medical Center, Brooklyn,  NY
  • Internship and Resident, Psychiatry, Mount Sinai Hospital, New York, NY

Dr. Rosenthal is a past president of both the American Academy of Addiction Psychiatry and the American Association for Technology in Psychiatry, a Distinguished Fellow of the American Psychiatric Association and a Fellow of the New York Academy of Medicine. Dr. Rosenthal has been appointed to the NY State Mental Health Services Council as well as receiving numerous awards and honors including the Founders Award of the American Academy of Addiction Psychiatry, more than ten years in New York Magazine's Best Doctors in New York and several years in The Best Doctors in America.

Dr. Rosenthal’s main research and clinical focus for more than 25 years has been on the evaluation and treatment of co-occurring substance use and other mental disorders. He was a Senior Fellow, SAMHSA Co-Occurring Disorders Center for Excellence and Co-Chairman of its National Steering Council, and is currently Senior Advisor to the Center for Excellence in Integrated Care. He has authored more than 80 peer-reviewed journal articles, invited reviews, book chapters, and books and serves on the editorial board of American Journal on Addictions. Dr. Rosenthal also maintains a private practice of psychotherapy and psychopharmacology for mood and addictive disorders.

-
Top

CME Accreditation

Intended Audience:Child and Adolescent Psychiatrists

Learning Objectives:Upon completion of this program, participants should be able to:

  • Explain pharmacotherapy for obsessive compulsive disorder in children and adolescents
  • Describe the effectiveness, safety, and tolerability across multiple pharmacological interventions for children and adolescents
  • Articulate strategies to work with dysfunctional and difficult families
  • Identify evidence-based augmentation for pharmacotherapies in treating depressed children
  • Interpret advances in neurobiology, terminology, and psychopharmacology for autism spectrum disorders
  • Classify treatment options for ADHD in children and adolescents

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of PeerPoint Medical Education Institute and American Physician Institute for Advanced Professional Studies, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to sponsor continuing medical education for physicians.

Designation Statement:

PeerPoint Medical Education Institute designates the live and enduring material formats for this educational activity for a maximum of 16.5 AMA PRA Category 1 credits™ (with 8 of these credits designated as Self-Assessment). Physicians should only claim credit commensurate with the extent of their participation in the activity. This CME activity was planned and produced in accordance with the ACCME Essentials.

The American Board of Psychiatry and Neurology has reviewed the 2012 Child & Adolescent Master Psychopharmacology Course and has approved this program as a part of a comprehensive Self-Assessment Program, which is mandated by the ABMS as a necessary component of Maintenance of Certification.

-
Top Top